Search
Browse
Statistics
Feeds

Small molecule specifically inhibiting microglial nitric oxide release could become a potential treatment for neuroinflammation

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
2MB
[thumbnail of Supporting Information] Other (Supporting Information)
644kB

Item Type:Article
Title:Small molecule specifically inhibiting microglial nitric oxide release could become a potential treatment for neuroinflammation
Creators: Jordan, P., Costa, A., Specker, E. ORCID logoORCID: https://orcid.org/0000-0002-9471-9520, Popp, O. ORCID logoORCID: https://orcid.org/0000-0001-6240-4666, Volkamer, A. ORCID logoORCID: https://orcid.org/0000-0002-3760-580X, Piske, R., Obrusnik, T., Kleissle, S., Stuke, K., Rex, A. ORCID logoORCID: https://orcid.org/0000-0003-3924-956X, Neuenschwander, M. ORCID logoORCID: https://orcid.org/0000-0002-3114-7975, von Kries, J.P. ORCID logoORCID: https://orcid.org/0000-0003-4716-4988, Nazare, M. ORCID logoORCID: https://orcid.org/0000-0002-1602-2330, Mertins, P. ORCID logoORCID: https://orcid.org/0000-0002-2245-528X, Kettenmann, H. ORCID logoORCID: https://orcid.org/0000-0001-8208-0291 and Wolf, S.A. ORCID logoORCID: https://orcid.org/0000-0003-0922-8418
Abstract:Microglia are the immune effector cells of the central nervous system (CNS) and react to pathologic events with a complex process including the release of nitric oxide (NO). NO is a free radical, which is toxic for all cells at high concentrations. To target an exaggerated NO release, we tested a library of 16 544 chemical compounds for their effect on lipopolysaccharide (LPS)-induced NO release in cell line and primary neonatal microglia. We identified a compound (C1) which significantly reduced NO release in a dose-dependent manner, with a low IC50 (252 nM) and no toxic side effects in vitro or in vivo. Target finding strategies such as in silico modelling and mass spectroscopy hint towards a direct interaction between C1 and the nitric oxide synthase making C1 a great candidate for specific intra-cellular interaction with the NO producing machinery.
Keywords:Cell Line, Lipopolysaccharides, Microglia, Neuroinflammatory Diseases, Nitric Oxide Synthase Type II, Nitric Oxide
Source:PLoS ONE
ISSN:1932-6203
Publisher:Public Library of Science
Volume:18
Number:2
Page Range:e0278325
Date:6 February 2023
Official Publication:https://doi.org/10.1371/journal.pone.0278325
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library